(Reuters Health) - Tests for BRCA1 and BRCA2 - gene mutations that raise the risk of breast and ovarian cancers - are not always done in U.S. women who are eligible to get them, a new study suggests.
Original Article: Not all women eligible for breast cancer gene tests are getting them